144 filings
8-K
ASH
Ashland Inc
8 May 24
Ashland signs definitive agreement to sell nutraceuticals business to Turnspire Capital Partners
7:00am
8-K
ASH
Ashland Inc
30 Apr 24
Ashland reports financial results1 for second quarter fiscal 2024; issues outlook for third quarter and full-year fiscal 2024
5:09pm
8-K
ASH
Ashland Inc
30 Apr 24
Departure of Directors or Certain Officers
7:30am
8-K
ASH
Ashland Inc
15 Apr 24
Ashland Board appoints Scott A. Tozier as new director
7:30am
8-K
ASH
Ashland Inc
26 Feb 24
Departure of Directors or Certain Officers
6:59am
8-K
kfrkn3t
30 Jan 24
Ashland reports financial results1 for first quarter fiscal 2024; issues outlook for second quarter and full-year fiscal 2024
5:10pm
8-K
nbszf5ppu7f
26 Jan 24
Submission of Matters to a Vote of Security Holders
4:45pm
8-K
af66gip1
17 Nov 23
Departure of Directors or Certain Officers
4:30pm
8-K
qn68bfngcdh
14 Nov 23
Departure of Directors or Certain Officers
5:27pm
8-K
q4ku59
8 Nov 23
Ashland reports financial results1 for fourth-quarter fiscal 2023; issues outlook for first-quarter fiscal 2024
5:14pm
8-K
lnbcm hnbz5
1 Nov 23
Results in the fourth-quarter reflect a customer-demand environment that was generally consistent with expectations
5:26pm
8-K
gdzgg 8ocd4z
24 Oct 23
Entry into a Material Definitive Agreement
4:15pm
8-K
o8hosrvf 7m5a5k2q
16 Aug 23
Departure of Directors or Certain Officers
5:17pm
8-K
q5yk2xoe0l2
25 Jul 23
Ashland reports financial results1 for third quarter of fiscal year 2023
5:21pm
8-K
ct7hkyj8
28 Jun 23
Regulation FD Disclosure
5:16pm
8-K
1ie2t 04ziow9
26 Jun 23
Departure of Directors or Certain Officers
5:03pm
8-K
qrq1omg
12 May 23
Ashland announces 15 percent increase in quarterly dividend, new dividend policy and $100 million share repurchase program
6:25am
8-K
ysq45jpnwtn0rnao
2 May 23
Sales of $603 million consistent with the prior-year quarter
5:30pm
8-K
0hmoq0m
20 Apr 23
Entry into a Material Definitive Agreement
2:52pm
8-K/A
xo8d4z
31 Jan 23
Submission of Matters to a Vote of Security Holders
5:26pm